A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics. - Wikidata - awgldk - TriplyDB

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

http://www.wikidata.org/entity/Q33752920

about

Focus on molecules: heparanase.Expression of heparanase in soft tissue sarcomas of adults.Heparanase cooperates with Ras to drive breast and skin tumorigenesis Tumorigenic and adhesive properties of heparanase.Heparanase enhances myeloma progression via CXCL10 downregulation.Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element Involvement of Heparanase in Empyema: Implication for Novel Therapeutic Approaches Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy Significance of heparanase in cancer and inflammation.Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

P2860

Q24618199-D6181C19-6F44-4254-B6B1-928A3FA52101 Q33634228-6D4C6F36-451B-46C6-8DE7-AA24822C2C56 Q34052534-43CF394F-4159-4954-BCAB-A10FB2A19FEF Q34137792-986DF286-84ED-4E6C-BF3D-440C25BAA53B Q34289445-0FC63443-88F6-4603-B03A-D24F0C1F9B42 Q34398151-77223D8F-81F2-4466-B38B-B4FD5C409D38 Q34516760-6DDC6149-7A5B-42AF-92CF-21A0651C2F9A Q35588864-397B4EBC-1AEF-4ECC-BA91-6F8BA2203EB3 Q35636604-27541CB8-D571-47F8-96A1-147BA55261EB Q35838889-D2DB1FE4-766B-4D4A-AD1C-7FA922865CA8 Q36070533-887DCB8C-48C2-4123-99D5-0CDAEC38FEE4 Q36101233-9F3F3993-74B9-4A35-850F-E5FC3A63B904 Q36542354-06D9E095-D10E-405E-B3C7-7E42784AF4D7 Q36739082-E872E72B-AD12-43B0-A873-0EE1FA431582 Q36919158-29240C73-1D14-44BA-B1BA-A7C0459ACA1F Q38333539-C6C08A4C-C5FD-4BBA-80A7-CB631BB104AD Q38718475-9A3C87F3-2672-4A51-B93E-61C637736043 Q38801721-E84CE24D-3429-46D9-A8AE-17E5F497874C Q47377873-965C680F-CAEE-4152-9B50-AA09B5F920D7

P2860

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

http://www.wikidata.org/entity/Q33752920

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

@ast

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

@en

type

label

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

@ast

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

@en

prefLabel

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

@ast

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

@en

P1433

Q33752920-A0765949-D5CE-40F0-80F6-8F241E708D87

P1476

Q33752920-F9BA651C-B4E9-4F69-86EB-49579105D8EA

P2093

Q33752920-04E62664-BD6E-4875-AF82-1D762B387082

Q33752920-0C79AABC-B82D-4763-A62A-1F9600C102D7

Q33752920-0E27F5FD-1E64-41FD-AF57-AC4C5A4FAB9A

Q33752920-53A42F89-6AE6-4A7D-9EE0-AE8C26D6A8A7

Q33752920-813B93BF-D6CB-4580-B87B-5FEDDD4986AB

Q33752920-8F176404-58E4-41FA-868C-AAC06F607BEA

Q33752920-AAAC0B1F-3081-41F3-8A6D-8711D8683E39

Q33752920-B0F9DE12-5B2D-4C25-BCE0-CED2BEAC8A56

Q33752920-B4B3DAE4-927A-4A36-BE55-8432F57D6C89

Q33752920-C59BC2DB-157F-4A35-91F6-54F59BBD3ADE

P2860

Q33752920-01FFD35A-3711-44F2-B36B-DB560C80147E

Q33752920-03E50EED-293A-45B2-8A32-62FD45E907A9

Q33752920-122BCAEA-26ED-4688-ADCB-82AB589AA0C0

Q33752920-198E3C29-EFAF-4A65-9635-ECE632FA29FD

Q33752920-1B628D77-EEB5-407A-94C9-C0A801E61C51

Q33752920-1DDB571E-3038-4440-92A3-43093547E5FF

Q33752920-1E91193F-A85C-4F22-ADFE-093554B76F91

Q33752920-377F8C0E-F102-409D-BF97-607B4F6537A6

Q33752920-3CD47EA1-1F3A-4CB9-A923-50225D348BC7

Q33752920-40136A19-81F3-4FC1-8335-78EC44E98E61

P304

Q33752920-74E27130-CDD7-448A-9331-50AD88B08A78

P31

Q33752920-5A2B053E-77C4-400D-96AA-7A18DC49B8C7

P356

Q33752920-0F45D77C-494E-4EE4-B998-E61418EA76A2

P407

Q33752920-4ED77B0C-4B5B-4910-9CB3-1FC22D929E44

P433

Q33752920-FD4B3256-3A4D-477B-B945-B140F45D76FE

P478

Q33752920-AD8BA999-159C-41AB-BD0B-D11CCBF131E9

P577

Q33752920-122F7165-496A-48D9-9635-AFF349012F9E

P698

Q33752920-44265F29-1457-47CD-86F7-283D74BFE94A

P932

Q33752920-5CD047AA-A73F-4B0D-9C29-F96055090BED

P356

P1433

P1476

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

@en

P2093

Flonia Levy-Adam

http://www.w3.org/2001/XMLSchema#string

Gil Arvatz

http://www.w3.org/2001/XMLSchema#string

Israel Vlodavsky

http://www.w3.org/2001/XMLSchema#string

Michal Ayalon-Sofer

http://www.w3.org/2001/XMLSchema#string

Neta Ilan

http://www.w3.org/2001/XMLSchema#string

Ofer Nativ

http://www.w3.org/2001/XMLSchema#string

Ronen Shemesh

http://www.w3.org/2001/XMLSchema#string

Svetlana Gingis-Velitski

http://www.w3.org/2001/XMLSchema#string

Uri Barash

http://www.w3.org/2001/XMLSchema#string

Victoria Cohen-Kaplan

http://www.w3.org/2001/XMLSchema#string

P2860

Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

Heparanase mediates cell adhesion independent of its enzymatic activity

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

Processing and activation of latent heparanase occurs in lysosomes

Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

Heparanase induces Akt phosphorylation via a lipid raft receptor

Human heparanase is localized within lysosomes in a stable form

RNA and disease

P304

1239-1248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.09-147074

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20007507

http://www.w3.org/2001/XMLSchema#string

P932

2845434

http://www.w3.org/2001/XMLSchema#string